Novel head-mounted device shows promise in alleviating depression symptoms

FHS
May 8, 2024
11:23 am

A head-mounted device that generates an ultra-low frequency ultralow magnetic field has been found to improve the symptoms of four male patients diagnosed with major depressive disorder.

Awakn Life Sciences Announces Credit Facility | Psychedelic Invest

Toronto, Ontario–(Newsfile Corp. – December 18, 2024) – Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”) a clinical-stage biotechnology

December 18, 2024

Updated: GSK takes victory lap with blockbuster sales for RSV vaccine

GSK is looking to ride the momentum from its RSV vaccine sales into 2024 and beyond. Meanwhile, it has cut three infectious disease candidates from

February 1, 2024

New study opens unprecedented opportunities for bioengineering vaccine adjuvants

A valuable molecule sourced from the soapbark tree and used as a key ingredient in vaccines, has been replicated in an alternative plant host for

January 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.